ITGAM and acute kidney injury: While the anti-CD11b antibody has been previously recognized for its impact on neutrophil-mediated effects in various diseases, this study provides a perspective on the potential role of the anti-CD11b antibody in improving microcirculation in cisplatin-induced AKI (28, 36).